Shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are taking a beating today on the back of earnings that did not live up to Wall Street expectations. The stock is trading down over 15% to $100.00. After analyzing the stock closely, I found that there is no solid support until a double bottom at $92.00. Note the stock chart below. This is where I will be looking to buy this biotech company.
Take note, I verify what I say and back it up here so you can see my true performance: verifiedinvesting.com/AnnabelleTrader
Take note, I verify what I say and back it up here so you can see my true performance: verifiedinvesting.com/AnnabelleTrader